Literature DB >> 3229843

Outcome of closed injuries exceeding 20-unit blood transfusion need.

E B Riska1, O Böstman, H von Bonsdorff, S Hakkinen, H Jaroma, O Kiviluoto, T Paavilainen.   

Abstract

A series of 129 patients with closed injuries receiving more than 20 units (1 unit = 500 ml) of blood within the first 48 h of accident was analysed. The transfusion policy included type-specific crossmatched whole blood stored with citrate phosphate-adenine as the main replacement. One unit of fresh whole blood was transfused for every 5 to 6 units of stored blood. Also platelet concentrates and fresh frozen plasma were in routine use. The patients required 340 surgical procedures, on average 2.6 per patient. Thrombocytopenia with a lowest recorded platelet count of less than 100,000/mm3 occurred in 81 patients (63 per cent) of whom 18 had disseminated intravascular coagulation. This serious complication seemed to be associated with large retroperitoneal blood accumulations, the latter possibly acting as an enhancing factor. The mortality rate in the whole series was slightly lower than recorded previously in the literature. Among patients receiving 21 to 39 blood units the mortality was 25 per cent and among those receiving 40 units or more the mortality was 52 per cent.

Entities:  

Mesh:

Year:  1988        PMID: 3229843     DOI: 10.1016/0020-1383(88)90044-7

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  3 in total

Review 1.  7-Ketocholesterol- and 7β-Hydroxycholesterol-Induced Peroxisomal Disorders in Glial, Microglial and Neuronal Cells: Potential Role in Neurodegeneration : 7-ketocholesterol and 7β-hydroxycholesterol-Induced Peroxisomal Disorders and Neurodegeneration.

Authors:  Thomas Nury; Aline Yammine; Franck Menetrier; Amira Zarrouk; Anne Vejux; Gérard Lizard
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Comparative evaluation of thrombocytopenia in adult patients receiving linezolid or glycopeptides in a respiratory intensive care unit.

Authors:  Zhaorui Zhang; Zhixin Liang; Huaidong Li; Liang'an Chen; Danyang She
Journal:  Exp Ther Med       Date:  2013-12-04       Impact factor: 2.447

3.  Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study.

Authors:  Carlos Casasnovas; Montserrat Ruiz; Aurora Pujol; Agatha Schlüter; Alba Naudí; Stéphane Fourcade; Misericordia Veciana; Sara Castañer; Antonia Albertí; Nuria Bargalló; Maria Johnson; Gerald V Raymond; Ali Fatemi; Ann B Moser; Francesc Villarroya; Manuel Portero-Otín; Rafael Artuch; Reinald Pamplona
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.